Family Medicine · Mooresville, NC
NPI
1023096211
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
478 Williamson Rd, Suite B
Mooresville, NC, 28117
Phone (704) 662-3627
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$60K
548 prescriptions
Company payments, 2025
$745
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alissandro R Castillo prescribed most often to Medicare patients was Atovaquone-Proguanil Hcl (Atovaquone/Proguanil Hcl), with 230 prescriptions and refills. In total Alissandro R Castillo wrote 548 Medicare prescriptions that cost $60K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl | 230 | 233 | 222 | $15K |
| Azithromycin Generic | 69 | 69 | 66 | $589 |
| Yf-Vax Yellow Fever Vaccine Live/Pf | 37 | 37 | 37 | $8,880 |
| Typhim Vi Typhoid Vi Polysacch Vaccine | 28 | 28 | 28 | $5,675 |
| Ipol Poliomyelitis Vaccine, Killed | 21 | 21 | 21 | $2,945 |
| Twinrix Hepatitis A And B Vaccine/Pf | 20 | 20 | Under 11 | $5,628 |
| Vaqta Hepatitis A Virus Vaccine/Pf | 18 | 18 | 16 | $3,225 |
| Acetazolamide Generic | 15 | 15 | 15 | $159 |
| Ixchiq Chikungunya Vaccine, Live/Pf | 13 | 13 | 13 | $7,205 |
| Boostrix Tdap Diphth,pertuss(Acell),tet Vac | 13 | 13 | 13 | $1,720 |
| Doxycycline Monohydrate Generic | 11 | 17 | Under 11 | $372 |
Brand drugs: 193 claims; generic drugs: 355 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alissandro R Castillo $745 ($745 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $465.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.